ExploreWatchlistsPricing
  1. JP-listed companies
  2. WAKAMOTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Effective tax rate (%)

WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512)

Market cap
¥12.3B
P/E ratio
61.1x
Wakamoto Pharmaceutical manufactures branded drugs, generic medicines, and health products like Koryoku Wakamoto for healthcare providers and consumers in Japan and internationally.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEffective tax rate (%) (Million JPY)YoY (%)
Mar 31, 202513.9-145.17%
Mar 31, 2024-30.8-201.99%
Mar 31, 202330.2-52.84%
Mar 31, 202264.1+283.33%
Mar 31, 202116.7-120.43%
Mar 31, 2020-81.8-790.08%
Mar 31, 201911.9-119.76%
Mar 31, 2018-60-182.08%
Mar 31, 201773.1-13.49%
Mar 31, 201684.5+33.11%
Mar 31, 201563.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat